Mouse Models of, and AAV Gene Therapy for, Propionic Acidemia

被引：0
|
作者：
Chandler, Randy J. [1 ]
Smith, Stephanie N. [1 ]
Venditti, Charles P. [1 ]
机构：
[1] NIH, MGMMGB, Bldg 10, Bethesda, MD 20892 USA
来源：
MOLECULAR THERAPY | 2020年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
250
引用
收藏
页码：118 / 119
页数：2
相关论文
共 50 条
  • [1] GENE THERAPY FOR PROPIONIC ACIDEMIA
    McGlinch, Erin
    ONeill, Jacqulyn
    Guenzel, Adam
    Barry, Michael A.
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 286 - 286
  • [2] Systemic gene therapy using an AAV44.9 vector rescues a neonatal lethal mouse model of propionic acidemia
    Chandler, Randy J.
    Di Pasquale, Giovanni
    Choi, Eun-Young
    Chang, David
    Smith, Stephanie N.
    Sloan, Jennifer L.
    Hoffmann, Victoria
    Li, Lina
    Chiorini, John A.
    Venditti, Charles P.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 30 : 181 - 190
  • [3] Effective gene therapy for propionic acidemia
    Chandler, Randy J.
    Chandrasekaran, Suma
    Carrillo-Carrasco, Nuria
    Venditti, Charles P.
    MOLECULAR GENETICS AND METABOLISM, 2011, 102 (03) : 274 - 274
  • [4] Comparison of Promiscuous and Tissue-Targeted AAV Gene Therapy for Systemic Propionic Acidemia Treatment
    Guenzel, Adam J.
    Hillestad, Matthew L.
    Barry, Michael A.
    MOLECULAR THERAPY, 2014, 22 : S137 - S137
  • [5] Defining Clinical and Laboratory Biomarkers in Propionic Acidemia to Guide AAV Gene Therapy Clinical Trial Endpoints
    Aima, Carolina I. Galarreta
    Shchelochkov, Oleg
    Sloan, Jennifer L.
    Hall, Camryn
    Gebremariam, Abigael
    Ferry, Susan C.
    Van Ryzin, Carol A.
    Manoli, Irini
    Venditti, Charles P.
    MOLECULAR THERAPY, 2024, 32 (04) : 296 - 297
  • [6] Short-Term Rescue of Neonatal Lethality in a Mouse Model of Propionic Acidemia by Gene Therapy
    Hofherr, Sean E.
    Senac, Julien S.
    Chen, Christopher Y.
    Palmer, Donna J.
    Ng, Philip
    Barry, Michael A.
    HUMAN GENE THERAPY, 2009, 20 (02) : 169 - 180
  • [7] Prevalence of Neutralizing Antibodies Against AAV2 and AAV9 Capsids in Propionic Acidemia (PA): Implications for Systemic Gene Therapy
    Hall, Camryn S.
    Sloan, Jennifer L.
    Galarreta, Carolina I.
    Shchelochkov, Oleg
    Manoli, Irini
    Venditti, Charles P.
    MOLECULAR THERAPY, 2024, 32 (04) : 298 - 298
  • [8] Systemic AAV GGene Therapy Rescues Murine Models of Propionic Acidemia Caused Mutations in Pccb from Neonatal Lethality
    Moise-Silverman, Joshua
    Chandler, Randy J.
    Hubbard, Brandon
    Venditti, Charles
    MOLECULAR THERAPY, 2019, 27 (04) : 201 - 201
  • [9] A Generalizable Approach to Extracting Relevant Biomarkers for AAV Gene Therapy from Natural History Datasets: Application to Propionic Acidemia
    Shchelochkov, Oleg
    Mccoy, Samantha
    Pass, Alexandra
    Myles, Jennifer
    Ferry, Susan
    Van Ryzin, Carol
    Schoenfeld, Megan
    Chlebowski, Colby
    Sloan, Jennifer
    Thurm, Audrey
    Chen, Kong Y.
    Manoli, Irini
    Venditti, Charles P.
    MOLECULAR THERAPY, 2022, 30 (04) : 476 - 477
  • [10] Anaplerotic therapy in propionic acidemia
    Longo, Nicola
    Price, Leisa B.
    Gappmaier, Eduard
    Cantor, Nancy L.
    Ernst, Sharon L.
    Bailey, Carrie
    Pasquali, Marzia
    MOLECULAR GENETICS AND METABOLISM, 2017, 122 (1-2) : 51 - 59
12345